Article ID Journal Published Year Pages File Type
8736562 Best Practice & Research Clinical Rheumatology 2017 14 Pages PDF
Abstract
Disease severity varies from mild to life threatening, and one of the most feared complications is AA amyloidosis. Effective therapies are available for many of the syndromes, including colchicine, IL-1 blockade and anti-TNF therapies, and there is an increasing interest in blocking interferon pathways.
Related Topics
Health Sciences Medicine and Dentistry Immunology, Allergology and Rheumatology
Authors
,